Summit Therapeutics (SMMT) Tax Rate (2019 - 2020)

Summit Therapeutics (SMMT) posted Tax Rate of 0.15% for Q4 2020, down 50.78% on a QoQ basis from 0.31% in Q3 2020, and up 70.0% year-over-year from 0.09% in Q1 2020.

Summit Therapeutics (SMMT) Tax Rate (2019 - 2020) Analysis & Trends

Summit Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 0.15% for Q4 2020.

  • Quarterly Tax Rate rose 70.0% year-over-year to 0.15% in Q4 2020, while the trailing twelve-month figure through Sep 2021 was 0.03% (down 27.0% YoY) and the FY2020 annual result came in at 0.4%, up 53.0% from the prior year.
  • Tax Rate was 0.15% for Q4 2020 at Summit Therapeutics, down from 0.31% in the prior quarter.
  • Across five years, Tax Rate topped out at 1.23% in Q2 2020 and bottomed at 1.77% in Q3 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -0.34
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 5.61
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 12.29
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 17.68
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 12.51
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -13.70
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Summit Therapeutics 10.60 Bn 10.00 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 0.15
Dec 31, 2020 0.15
Dec 31, 2020 0.15
Sep 30, 2020 0.31
Sep 30, 2020 0.31
Sep 30, 2020 0.31
Jun 30, 2020 1.23
Jun 30, 2020 1.23
Jun 30, 2020 1.23
Mar 31, 2020 -0.90
Mar 31, 2020 -0.90
Mar 31, 2020 -0.90
Dec 31, 2019 -0.54
Dec 31, 2019 -0.54
Dec 31, 2019 -0.54
Sep 30, 2019 -1.77
Sep 30, 2019 -1.77
Sep 30, 2019 -1.77